Polly A. Murphy
Disclosed holdings of Polly A. Murphy as of 2026-06-18: 122K shares of Atea Pharmaceuticals (AVIR), worth about $534K at the last close. In 12 months: bought…
What Polly A. Murphy reported holding
As of the latest filing on , Polly A. Murphy reported holding 121,745 shares of Atea Pharmaceuticals (AVIR), worth about $534K at the last close of $4 (Oct 19, 2026). In the last 12 months, Polly A. Murphy bought $25K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Atea Pharmaceuticals AVIR | 121,745 | 122K direct | $4 | $534K | Jun 18, 2026 |
Is this Polly A. Murphy’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2021
Polly A. Murphy bought shares on the open market in 2021, 2022 and 2026 across 2 companies.
Polly A. Murphy reported 3 open-market purchases and 0 sales since 2021; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2022 | 1×1 trade | — |
| 2021 | 1×1 trade | — |
Insider at 2 companies
- Atea Pharmaceuticals AVIR2021–2026 · 2 purchases, 0 sales
- Celcuity CELC2022 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Atea Pharmaceuticals AVIR
Polly A. Murphy reported 2 open-market purchases and 0 sales here, 2021 to 2026.
- Market value
- $352M
- Last close
- $4.39
- 12 months
- +43.5%
- Against the S&P 500
- +28.1 pts
- Celcuity CELC
Polly A. Murphy reported 1 open-market purchase and 0 sales here, 2022.
- Market value
- $2.79B
- Last close
- $57.12
- 12 months
- +9.9%
- Against the S&P 500
- −5.4 pts
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Polly A. Murphy's trades
Has Polly A. Murphy bought shares on the open market?
Polly A. Murphy bought shares on the open market in 2021, 2022 and 2026 across 2 companies.
When did Polly A. Murphy last buy or sell shares?
In SEC filings since 2021: the latest open-market purchase is from 2026; no open-market sale is on record.
Which companies has Polly A. Murphy traded as an insider?
2 companies: Atea Pharmaceuticals (AVIR, 2021–2026), Celcuity (CELC, 2022).